FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Laurus Labs IPO.
April 18, 2024 9:13:50 AM
Rajesh Palviya, Head Technical Research at Axis Securities, on Thursday selected Laurus Labs Ltd as one of his top picks for the day. "The stock has seen a reversal in the previous session," the ...
Published by : Business Today on MSNJanuary 25, 2024 6:47:00 PM
3 min read 25 Jan 2024, 10:47 AM IST Trade Now According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Laurus Labs stock prices have seen a gap-down opening and have ...
Published by : MintApril 16, 2024 3:30:00 AM
Laurus Labs Ltd share price was up by 3.07% from the previous closing price of ?429.95. Who are peers of Laurus Labs Ltd? The peers of Laurus Labs Ltd are Sun Pharmaceuticals Industries Ltd ...
Published by : Business TodayApril 18, 2024 10:43:59 PM
In late afternoon trading, shares had retreated to about $105, still a 19% rise from Wednesday�s close. Initial pricing for the shares�6.56 million were sold at $88, generating more than $577 million ...
Published by : Fortune on MSNApril 18, 2024 9:46:00 PM
The two companies follow Reddit and Astera Labs out of the private markets, after both the social media company and datacenter connectivity hardware play continue to trade above their IPO prices.
Published by : TechCrunchApril 10, 2024 2:47:00 AM
The PE firm's other investments in the Indian healthcare sector include Meril Life Sciences, MedPlus, Laurus Labs, and Metropolis Healthcare. 2DG has been given emergency approval by the Drugs ...
Published by : health.economictimes.indiatimesApril 18, 2024 1:47:00 PM
Speciality chemicals company Kronox Lab Sciences has received Sebi's go ahead to raise funds through an initial public offering (IPO), an update with the capital markets regulator showed on Thursday.
Published by : devdiscourseMarch 20, 2024 5:43:00 PM
IPO watchers expect it to debut this week. Update: Astera Labs priced its IPO at $36 per share, above its raised range. More when it starts trading. For more, hit play below: While Reddit's IPO ...
Published by : YahooJuly 13, 2022 9:24:00 AM
Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished ...
Published by : MintMarch 20, 2024 3:30:00 AM
IPO watchers expect it to debut this week. Update: Astera Labs priced its IPO at $36 per share, above its raised range. More when it starts trading. For more, hit play below: While Reddit's IPO could ...
Published by : Yahoo NewsLaurus Labs IPO Listing Date
› Listing Date: Monday, December 19, 2016
› BSE Script Code: 540222
› NSE Symbol: LAURUSLABS
› Listing In: ‘B’ Group of Securities
› ISIN: INE947Q01010
› Issue Price: Rs. 428.00 Per Equity Share
› Face Value: Rs. 10.00 Per Equity Share
Laurus Labs Ltd IPO Allotment Status is now available online.
Laurus Labs Ltd is Hyderabad based pharmaceutical company engaged in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
The Initial Public Offer of Laurus Labs subscribed 4.53 times (1.58 times in retail). Public Issue of Laurus Labs was closed for subscription on Dec 08, 2016.
Laurus Labs Ltd IPO to open on Dec 06, 2016 and close for subscription on Dec 08, 2016. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level. The equity shares of the company to be list at BSE and NSE.
Laurus Labs Ltd is entering in the capital markets with an initial public offering, Fresh Issue aggregating up to Rs 300.00 Cr and Offer for Sale of 24,107,440 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level.
Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
The issue opens on Dec 06, 2016 and closes for subscription on Dec 08, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Laurus Labs IPO is proposed to open on December 6, 2016. The IPO application ends on December 8, 2016.
Retail investors can apply in the retail or non-institutional investor category from December 6, 2016 to December 8, 2016. The Laurus Labs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Laurus Labs IPO will open for subscription on December 6, 2016. The public issue will close on December 8, 2016.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|